Prostate Cancer Genetic Signatures

A better understanding of the genetics of prostate cancer announced today will help us improve treatment and outcomes.

Researchers from Cancer Research UK and Addenbrookes Hospital have identified the cancer genetic signatures of five core types of prostate cancer and mapped these to outcomes.

250 tissue samples removed at surgery were analysed for genetic characteristics. The outcomes of the patients were tracked over time and mapped to the genetic “signature”. This has helped identify five core types of prostate cancer.

Commenting on the news, Dr Daniel Saunders, Consultant Oncologist with The Nottingham Oncology Group said: This is good news in advancing our understanding of prostate cancer. We have an increasing number of treatments available, many of which have good outcomes, but we need this sort of genetic information to predict the behaviour of each cancer and individualise therapy for each patient.

Latest News

  • October 3, 2015
    Early Docetaxel for prostate cancer improves survival

    Early treatment with Docetaxel chemotherapy imp...

    Read More
  • July 30, 2015
    Prostate Cancer Genetic Signatures

    A better understanding of the genetics of prost...

    Read More
  • May 13, 2015
    Where are the voices for radiotherapy?

    It is not well publicised – but the main ...

    Read More